首页> 外国专利> METHOD FOR TREATING CIRCUMSCRIBED SCLERODERMA WITH CLINICALLY SUBSTANTIATED ETIOTROPIC AND PATHOGENETIC THERAPY

METHOD FOR TREATING CIRCUMSCRIBED SCLERODERMA WITH CLINICALLY SUBSTANTIATED ETIOTROPIC AND PATHOGENETIC THERAPY

机译:临床证实的骨质疏松症和流行病治疗治疗硬化性皮脂病的方法

摘要

A method for treating circumscribed scleroderma with clinically substantiated etiotropic and pathogenetic therapy comprises the following drugs: Vobenzyme representing the combination of highly active enzymes of plant and animal origin possessing immunomodulating, anti-inflammatory, fibrinolytic and secondary analgesic properties (in the form of dragee), Cuprenil possessing anti-inflammatory effect and interfering with collagen synthesis by cleaving the cross links between synthesizing tropocollagen molecules (in the form of capsules) and Medobiotin. In addition, the physiotherapeutic procedures are used: application of Saki muds, ionophoresis with multienzyme ointment Vobe-mugos, and the massage.
机译:一种通过临床证实的正性和病原性疗法治疗外接硬皮病的方法,包括以下药物:代表具有动免疫,抗炎,纤溶和二次止痛特性(糖衣杏仁形式)的动植物来源的高活性酶组合的伏本酶,Cuprenil具有抗炎作用,并通过裂解合成的原胶原蛋白分子(以胶囊形式)和Medobiotin之间的交联而干扰胶原蛋白的合成。此外,还使用了理疗程序:使用Saki泥浆,用多酶软膏Vobe-mugos进行离子导入和按摩。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号